Skip to main content

Day: November 18, 2020

User Friendly And Informative Hero FinCorp Retail Customer Service App

Choosing the right type of loan product is the first step towards getting your finances right. If you are in need of funds, you will be on the lookout for lenders who offer a loan at low interest rates. Given the number of loan options in the market today, it is important to consider your needs and choose a loan product that is in alignment with your goals. Hero FinCorp is a well known name in the industry and they offer complete information about their products on the Hero FinCorp retail customer service app. The lender has a strong presence across the length and breadth of the country and strives to help individuals turn their dreams into a reality. Hero FinCorp has loan products for your personal and professional goals. They offer a loan for the purchase of a two wheeler, loan for a used car, unsecured loan, loan against a residential...

Continue reading

Iceland Seafood International hf: Iceland Seafood announces the sale of the Malaga based distribution company Ecomsa

A logical step following the merger of all Spanish production into Barcelona earlier this year.   Iceland Seafood Ibérica, the Spanish subsidiary of Iceland Seafood International (“Iceland Seafood”) announces signing of an agreement to sell its Málaga based production and distribution company Elaboración de Congelados Málaga SAU (Ecomsa) to Aquamar Gold SL, an Andalusian seafood distribution company based in Malaga. The sale is a direct consequence of Iceland Seafood moving all its production in Spain to its Barcelona factory, after which Ecomsa became a focused distribution company in direct sales to restaurants and hotels mainly  – which is a business outside the core strategy of Iceland Seafood Ibérica. In accordance with the sales and purchase agreement, 100% shares in Ecomsa are sold for €346k.  Ecomsa sales in the first nine...

Continue reading

Iceland Seafood International hf: Iceland Seafood significantly expands its footprint in the Irish seafood market for retail

Completes the acquisition of all shares of Carr & Sons Seafood Ltd (“Carr & Sons”) in line with letter of intent signed on August 28thBuys the remaining 33% of Oceanpath Ltd., partly with parent company sharesTotal sales in Ireland to exceed €50m, selling into all major retailers in IrelandOceanpath acquires Carr & SonsOceanpath, the Irish subsidiary of Iceland Seafood International (“Iceland Seafood”), has completed the acquisition from Mondi Group AB of Carr & Sons Seafood Limited Ltd (“Carr & Sons”) and the sister company Mondi Properties Ltd which owns the production facilities. Carr & Sons is  a significant seafood player in Ireland focused on production of high-quality salmon products for retail.  The consideration for the share capital was €6.5m as previously disclosed at signing of LOI on August 28th...

Continue reading

Nexstim Plc signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project

Company announcement, Inside information, Helsinki, 18 November 2020 at 11.00 am (EET)Nexstim Plc signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research projectNexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces that it has received an order and signed a purchase agreement to develop two prototype systems enabling introduction of a novel research tool for probing and diagnosing the brain.  The buyer of the prototype systems is a foundation based in the United States. The buyer will donate the equipment to certain designated third-party institutions in the United States and Europe. These institutions will conduct the actual research.The two systems ordered are medical device prototypes based on Nexstim’s Navigated Brain Stimulation (NBS) System...

Continue reading

Nexstim Oyj on allekirjoittanut 0,9 miljoonan euron arvoisen sopimuksen kahden prototyyppilaitteiston kehittämisestä ja toimittamisesta tutkimusprojektia varten

Yhtiötiedote, sisäpiiritieto, Helsinki, 18.11.2020 klo 11.00 (EET)Nexstim Oyj on allekirjoittanut 0,9 miljoonan euron arvoisen sopimuksen kahden prototyyppilaitteiston kehittämisestä ja toimittamisesta tutkimusprojektia vartenNexstim Plc (NXTMH:HEX, NXTMS:STO) (jäljempänä Nexstim tai Yhtiö) ilmoittaa saaneensa tilauksen ja allekirjoittaneensa sopimuksen kahdesta tutkimusprojektia varten kehitettävästä prototyyppilaitteistosta. Tutkimusprojektissa näiden laitteistojen avulla pyritään ottamaan käyttöön uusi työkalu aivojen tutkimiseen ja diagnosointiin.Prototyyppilaitteistojen ostaja on yhdysvaltalainen säätiö. Ostaja lahjoittaa laitteistot tietyille kolmannen osapuolen laitoksille Yhdysvalloissa ja Euroopassa. Nämä laitokset tekevät varsinaisen tutkimustyön.Tilatut laitteistot ovat lääkinnällisiä laiteprototyyppejä, jotka perustuvat Nexstimin...

Continue reading

Nexstim Abp tecknar avtal värt 0,9 miljoner euro om framtagning och leverans av två prototypsystem för forskningsprojekt

Företagsmeddelande, insiderinformation, Helsingfors, 18.11.2020 kl. 11.00 (EET)Nexstim Abp tecknar avtal värt 0,9 miljoner euro om framtagning och leverans av två prototypsystem för forskningsprojektNexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) meddelar att det har fått en order och tecknat ett avtal om framtagning av två prototypsystem för ett forskningsprojekt som ska utveckla ett nydanande verktyg för sondering och diagnostisering av hjärnan. Köparen av prototypsystemen är en stiftelse med hemvist i USA. Köparen har för avsikt att överlåta utrustningen till utsedda tredjepartsinstitutioner i USA och i Europa som utför det egentliga forskningsarbetet.Beställningen gäller två system som bygger på Nexstims system för navigerad hjärnstimulering (Navigated Brain Stimulation, NBS) på nTMS-plattformen SmartFocus®. I detta...

Continue reading

Deutschland meistert COVID-19-Herausforderung dank rascher Umstellung aufs Homeoffice – mit besonderem Fokus auf Sicherheitsfragen

FRANKFURT, Nov. 18, 2020 (GLOBE NEWSWIRE) — Die meisten deutschen Unternehmen haben die Umstellung auf das Homeoffice im Zuge der COVID-19-Pandemie erfolgreich gemeistert und schnell Hardware beschafft, Anwendungen für die Zusammenarbeit bereitgestellt und die erforderlichen Internetbandbreiten ermöglicht, so eine heute veröffentlichte Studie der Information Services Group (ISG) (Nasdaq: III), ein führendes, globales Marktforschungs- und Beratungsunternehmen im Technologie-Segment.Laut der ISG Provider Lens™–Studie „Digital Workplace of the Future – Services & Solutions Report Germany 2020“ haben die meisten deutschen Unternehmen die Technologie- und Infrastrukturtransformation geschickt bewältigt, die für eine Ausweitung der Arbeit vom Homeoffice aus auf Tausende von Mitarbeiter erforderlich war. Für deutsche Unternehmen...

Continue reading

Germany Rises to COVID-19 Challenge with Rapid Transition to Remote Work, Close Attention to Security Concerns

FRANKFURT, Germany, Nov. 18, 2020 (GLOBE NEWSWIRE) — Most German companies rose to the challenge when forced to quickly implement work-from-home programs in response to the COVID-19 pandemic, smoothly sourcing devices, providing collaboration tools and enabling bandwidth, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.The 2020 ISG Provider Lens™ Digital Workplace of the Future – Services & Solutions report for Germany found most companies skillfully managed the technology and infrastructure transformation required to extend remote work to thousands of employees. The challenge was especially steep for German enterprises because the country had been slow to accept remote work due to security concerns, union objections and cultural...

Continue reading

Positive results from Acarix study presented at ISPOR, a leading health economics conference

Press releaseMalmö, Sweden November 18, 2020Positive results from Acarix study presented at ISPOR, a leading health economics conferenceAcarix AB (publ) today announced that the company’s real-life data analysis, made in co-operation with clinics in Germany and Austria, is published as a poster presentation and abstract at ISPOR, the leading European conference for health economics and outcomes research, which is held virtually November 16-19, 2020.The study compared two patient sets, 1030 patients from Germany and Austria and 1501 from the DanNICAD-1 trial in Denmark and the conclusion reached is that “In clinical trials, ultra-sensitive phonocardiography has proven to be a clinically relevant diagnostic measurement. The use in real world has demonstrated that neither patient demographics nor test results differ relevantly from the trial...

Continue reading

Positiva resultat från Acarix-jämförelseanalys presenterades på den ledande hälsoekonomiska konferensen ISPOR

PressmeddelandeMalmö, Sverige, 18 november 2020Positiva resultat från Acarix-jämförelseanalys presenterades på den ledande hälsoekonomiska konferensen ISPORAcarix AB (publ) meddelade idag att bolagets analys av reell användning av CADScor®System, gjord i samarbete med kliniker i Tyskland och Österrike, presenteras som en poster på ISPOR, den ledande europeiska konferensen för hälsoekonomi och utfallsforskning, som hålls virtuellt den 16–19 november 2020.Analysen jämför två patientgrupper. 1 030 patienter vilka erhållit ett CADScor® test på kliniker i Tyskland och Österrike ställs mot 1 501 patienter från DanNICAD-1-studien som gjorts i Danmark. Slutsatsen visar att ultrakänslig fonokardiografi i kliniska studier ter sig vara ett relevant diagnostiskt verktyg även i reell praxis. Analysen av patientdata från klinikerna i Tyskland och Österrike...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.